MedPath

Dicyclomine HCl

These highlights do not include all the information needed to use DICYCLOMINE HYDROCHLORIDE INJECTION safely and effectively. See Full Prescribing Information for DICYCLOMINE HYDROCHLORIDE INJECTION. DICYCLOMINE HYDROCHLORIDE injection, for intramuscular use. Initial U.S. Approval: 1950

Approved
Approval ID

be216fa1-e509-4ae5-a62a-550881d090ae

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 22, 2023

Manufacturers
FDA

Nexus Pharmaceuticals LLC

DUNS: 620714787

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Dicyclomine Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code14789-010
Application NumberANDA206468
Product Classification
M
Marketing Category
C73584
G
Generic Name
Dicyclomine Hydrochloride
Product Specifications
Route of AdministrationINTRAMUSCULAR
Effective DateSeptember 22, 2023
FDA Product Classification

INGREDIENTS (4)

Sodium ChlorideInactive
Code: 451W47IQ8X
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
DICYCLOMINE HYDROCHLORIDEActive
Quantity: 10 mg in 1 mL
Code: CQ903KQA31
Classification: ACTIB
Dicyclomine HydrochlorideActive
Quantity: 10 mg in 1 mL
Code: CQ903KQA31
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.